Y
ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Respiratory · Lancet · 2026-11-14

In 558 African infants with HIV and severe pneumonia, empirical TB treatment did not reduce 12-month mortality versus test- and clinically guided treatment (48% vs 43% died; adjusted HR 1·12, 95% CI 0·87–1·43). 46% of the guided group started TB treatment anyway.

RCTn = 558
Domínguez-Rodríguez et al. Empirical tuberculosis treatment in infants living with HIV hospitalised with severe pneumonia in Africa (EMPIRICAL): a multicentre, randomised, open-label, 2 × 2 factorial, controlled superiority trial
Respiratory · BMJ · 2026-11-04

In 400 children aged 2–6 undergoing adenotonsillectomy, ventilation with a laryngeal mask airway led to fewer perioperative respiratory adverse events than an endotracheal tube (22.5% v 57.5%; risk difference −35.0 points). No serious adverse events occurred.

RCTn = 400
Han et al. Perioperative respiratory adverse events in children undergoing adenotonsillectomy with laryngeal mask airway versus endotracheal tube ventilation: multicentre, randomised controlled trial
Respiratory · Lancet · 2026-10-31

In 424 children with early moderate-to-severe ARDS, neither prone positioning nor HFOV increased 28-day ventilator-free days vs supine or conventional ventilation; trial stopped early for futility and slow enrolment. Prone raised airway plugging and pressure injuries.

RCTn = 424
Curley et al. Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial
Respiratory · Lancet Respir Med · 2026-09-18

Individual-participant meta-analysis of 84,128 TB contacts with infection: preventive treatment cut 1-year TB risk in medium- and low-burden settings (HR 0·14 and 0·21) with long-lasting protection, but not significantly in high-burden settings (HR 0·57, 95% CI 0·31–1·07).

Meta-analysisn = 84,128
Linde et al. Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis
Respiratory · Lancet Respir Med · 2026-09-15

Meta-analysis of 30 studies (8130 patients) with suspected asthma: FeNO had good accuracy in adults (AUC 0·80) and fair accuracy in children (0·75). In adults, blood eosinophils were weak (AUC 0·65) and added nothing; a prospective adult cohort (n=123) replicated this.

Meta-analysisn = 8,130
Roy et al. Accuracy of type 2 inflammatory biomarkers to diagnose asthma in adults and children: a meta-analysis of 30 studies with prospective validation in an adult primary care cohort
Respiratory · Lancet Respir Med · 2026-08-25

In 166 patients with resected early-stage ALK-positive NSCLC, adjuvant crizotinib for up to 2 years did not improve disease-free survival vs observation or placebo (median 74·6 vs 75·1 months; HR 1·08, 95% CI 0·61–1·90). Grade ≥3 events on crizotinib: 58%.

RCTn = 166
Gerber et al. Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial

Sign in to react

Enter your email and we send a one-time link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.